02126.HK
JW (Cayman) Therapeutics Co. Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 2.22
−0.45%Leverage
- Debt / equity
- 0.56x
- Net debt / equity
- -0.30x
- Debt / assets
- 0.31x
- Debt / EBITDA
- -1.28x
- Net debt / EBITDA
- 0.69x
Liquidity & coverage
- Current ratio
- 1.43x
- Quick ratio
- 1.27x
- Cash ratio
- 1.24x
- Interest coverage
- -30.70x
- EBITDA / interest
- -22.58x
- Working capital
- HKD 160.2M
Cash & dividend
- FCF / debt
- -0.44x
- Cash flow / debt
- -0.43x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026